E.S.G. Stroes

1.2k total citations
22 papers, 888 citations indexed

About

E.S.G. Stroes is a scholar working on Surgery, Cancer Research and Molecular Biology. According to data from OpenAlex, E.S.G. Stroes has authored 22 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 7 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in E.S.G. Stroes's work include Lipoproteins and Cardiovascular Health (10 papers), Cancer, Lipids, and Metabolism (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). E.S.G. Stroes is often cited by papers focused on Lipoproteins and Cardiovascular Health (10 papers), Cancer, Lipids, and Metabolism (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). E.S.G. Stroes collaborates with scholars based in Netherlands, United States and Germany. E.S.G. Stroes's co-authors include Hans L. Mooij, Max Nieuwdorp, Hans Vink, Marijn C. Meuwese, Bregtje A. Lemkes, Reinier O. Schlingemann, Hein J. Verberne, Lysette N. Broekhuizen, F. Holleman and Rakesh S. Birjmohun and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and Kidney International.

In The Last Decade

E.S.G. Stroes

21 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.S.G. Stroes Netherlands 12 226 199 191 150 148 22 888
Benjamin Funke Germany 15 203 0.9× 286 1.4× 214 1.1× 372 2.5× 233 1.6× 24 1.4k
Dae Hyun Lee United States 14 208 0.9× 74 0.4× 147 0.8× 193 1.3× 141 1.0× 53 947
Margien G. S. Boels Netherlands 8 239 1.1× 59 0.3× 103 0.5× 73 0.5× 125 0.8× 10 636
George Pavlidis Greece 19 89 0.4× 200 1.0× 153 0.8× 189 1.3× 162 1.1× 74 1.2k
David M. Moskowitz United States 19 406 1.8× 175 0.9× 361 1.9× 178 1.2× 98 0.7× 36 1.2k
Lysette N. Broekhuizen Netherlands 9 275 1.2× 34 0.2× 138 0.7× 76 0.5× 120 0.8× 16 756
Lynelle P. Smith United States 10 254 1.1× 147 0.7× 105 0.5× 195 1.3× 247 1.7× 14 863
Kazutomo Sawai Japan 14 194 0.9× 106 0.5× 178 0.9× 499 3.3× 161 1.1× 17 1.6k
Ajay Kher United States 12 39 0.2× 109 0.5× 151 0.8× 287 1.9× 182 1.2× 26 994
Alessandra Stasi Italy 21 47 0.2× 211 1.1× 229 1.2× 322 2.1× 115 0.8× 45 1.1k

Countries citing papers authored by E.S.G. Stroes

Since Specialization
Citations

This map shows the geographic impact of E.S.G. Stroes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.S.G. Stroes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.S.G. Stroes more than expected).

Fields of papers citing papers by E.S.G. Stroes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.S.G. Stroes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.S.G. Stroes. The network helps show where E.S.G. Stroes may publish in the future.

Co-authorship network of co-authors of E.S.G. Stroes

This figure shows the co-authorship network connecting the top 25 collaborators of E.S.G. Stroes. A scholar is included among the top collaborators of E.S.G. Stroes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.S.G. Stroes. E.S.G. Stroes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartoli‐Leonard, Francesca, Malcolm P. Rogers, Mark C. Blaser, et al.. (2022). Inhibition of novel lipoprotein(a) receptor major facilitator superfamily domain containing 5 (MFSD5) reduces development of aortic valve calcification. Cardiovascular Research. 118(Supplement_1). 1 indexed citations
2.
Larsen, Lars Emil, Jos C. Jansen, Donna Conlon, et al.. (2021). Defective Lipid Droplet–Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115. Cellular and Molecular Gastroenterology and Hepatology. 13(2). 583–597. 18 indexed citations
3.
Hoogeveen, Renate M., Nick S. Nurmohamed, V. Zampoleri, et al.. (2020). Improved cardiovascular risk prediction using plasma proteomics in primary prevention. Atherosclerosis. 315. e27–e27. 1 indexed citations
4.
Neidhart, Michel, Katerina Laskari, Niels P. Riksen, et al.. (2019). Oligomeric S100A4 Is Associated With Monocyte Innate Immune Memory and Bypass of Tolerance to Subsequent Stimulation With Lipopolysaccharides. Frontiers in Immunology. 10. 791–791. 30 indexed citations
5.
6.
Hegele, Robert A., Matt Ban, Jian Wang, et al.. (2017). Clinical and Biochemical Features of Different Molecular Etiologies of Familial Chylomicronemia. Journal of clinical lipidology. 11(3). 831–832.
7.
Stoekenbroek, Robert M., E.S.G. Stroes, & G. Kees Hovingh. (2014). ApoA-I Mimetics. Handbook of experimental pharmacology. 224. 631–648. 36 indexed citations
8.
Besseling, Joost, G. Kees Hovingh, & E.S.G. Stroes. (2013). Antisense oligonucleotides in the treatment of lipid disorders: pitfalls and promises.. PubMed. 71(3). 118–22. 7 indexed citations
9.
Wijk, Diederik F. van, Adriaan G. Holleboom, Raphaël Duivenvoorden, et al.. (2012). ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden. European Heart Journal. 34(4). 286–291. 54 indexed citations
10.
Bisoendial, Radjesh J., E.S.G. Stroes, & Paul P. Tak. (2011). Critical Determinants of Cardiovascular Risk in Rheumatoid Arthritis. Current Pharmaceutical Design. 17(1). 21–26. 17 indexed citations
11.
Broekhuizen, Lysette N., Bregtje A. Lemkes, Hans L. Mooij, et al.. (2010). Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia. 53(12). 2646–2655. 317 indexed citations
12.
Bisoendial, Radjesh J., et al.. (2010). The Prothrombotic State in Rheumatoid Arthritis: An Additive Risk Factor for Adverse Cardiovascular Events. Seminars in Thrombosis and Hemostasis. 36(4). 452–457. 23 indexed citations
13.
Holleboom, Adriaan G., Raphaël Duivenvoorden, Bas van den Bogaard, et al.. (2010). P216 CARRIERS OF LCAT GENE MUTATIONS HAVE INCREASED ATHEROSCLEROSIS: A 3.0 TESLA MRI STUDY. Atherosclerosis Supplements. 11(2). 61–61. 2 indexed citations
14.
Bisoendial, Radjesh J., E.S.G. Stroes, & Paul P. Tak. (2009). Where the immune response meets the vessel wall.. PubMed. 67(8). 328–33. 8 indexed citations
15.
Nieuwdorp, Max, Marijn C. Meuwese, Hans L. Mooij, et al.. (2008). Tumor necrosis factor-α inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis. 202(1). 296–303. 140 indexed citations
16.
Kastelein, John J.P., Fatima Akdim, E.S.G. Stroes, et al.. (2008). Simvastatin with or without ezetimibe in familial hypercholesterolemia (vol 358, pg 1431, 2008). New England Journal of Medicine. 358(18). 10 indexed citations
17.
Veer, Cornelis van ′t, Petra S. van den Pangaart, Marieke A. D. van Zoelen, et al.. (2007). Induction of IRAK-M Is Associated with Lipopolysaccharide Tolerance in a Human Endotoxemia Model. The Journal of Immunology. 179(10). 7110–7120. 143 indexed citations
18.
Birjmohun, Rakesh S., et al.. (2007). Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients. Current Medical Research and Opinion. 23(7). 1707–1713. 22 indexed citations
19.
Birjmohun, Rakesh S., Wim A. van der Steeg, E.S.G. Stroes, & J Kastelein. (2006). [The role of the high-density lipoprotein (HDL) particle in atherogenesis and potential methods to increase HDL concentrations].. PubMed. 150(41). 2245–50. 4 indexed citations
20.
Stroes, E.S.G., et al.. (1999). Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects. Kidney International. 55(3). 1005–1010. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin Funke Breakdown of academic impact, for papers by Dae Hyun Lee Breakdown of academic impact, for papers by Margien G. S. Boels Breakdown of academic impact, for papers by George Pavlidis Breakdown of academic impact, for papers by David M. Moskowitz Breakdown of academic impact, for papers by Lysette N. Broekhuizen Breakdown of academic impact, for papers by Lynelle P. Smith Breakdown of academic impact, for papers by Kazutomo Sawai Breakdown of academic impact, for papers by Ajay Kher Breakdown of academic impact, for papers by Alessandra Stasi
Rankless by CCL
2026